Gitnux/Report 2026

Fertility Tech Industry Statistics

The IVF market is projected to reach $43.7 billion by 2033 from $30.1 billion in 2026, explore company coverage, software revenue, and AI workflow adoption figures.
12Statistics
22Sources
3Sections
1Visuals
14mRead
Fertility Tech Industry Statistics
How this report is researched
01Editorial Scope

Gitnux editors write the brief first: the topic, the inclusion rules, and the frame for what belongs.

02Source Research

Agents search the published record and log every extracted figure back to the passage it came from.

Read our full methodology →

Search agents attach provenance to every extracted figure.

Next review: within 28 days

01 Industry overview

The fertility tech industry at a glance

The fertility tech industry is anchored by a global IVF market valued at $28.5 billion in 2025, while digital tracking, AI-enabled diagnostics, laboratory equipment and fertility benefits expand the technology base.

$28.5B[3]
Global IVF market, 2025
5.5%[3]
IVF market CAGR, 2026–2033
100,158
U.S. IVF babies, 2024
37.0%[3]
Europe IVF market share, 2025
Market size
The global in-vitro fertilization market was valued at $28.5 billion in 2025, according to Grand View Research. This is a useful commercial proxy for the clinical and laboratory core of fertility tech, which also includes digital platforms, diagnostics, genetic testing and benefits technology.[3]
Forecast & CAGR
The IVF market is projected to reach $43.7 billion by 2033 from $30.1 billion in 2026, representing a 5.5% CAGR from 2026 to 2033. Within digital fertility, fertility-tracking apps are forecast to grow from $131.69 billion in 2026 to $371.20 billion in 2034 at a 13.83% CAGR, although this estimate covers a narrower and differently defined segment.[3][8]
Market share & regions
Europe held the largest IVF market share at 37.0% in 2025. North America led the fertility-tracking-app segment with 44.51% of global revenue in 2025, while Asia-Pacific is forecast to be the fastest-growing regional market through 2034.[3][8]
Segmentation
IVF technology is segmented by instruments, procedure type, providers and region; culture media was the largest instrument segment at approximately 41.0% of revenue in 2025, while fertility clinics were the leading provider segment. Fertility-tracking apps are segmented by Android, iOS and other platforms, applications, end users and regions.[3][8]
Key players & concentration
The market includes equipment, consumables, software, clinics, benefits platforms and consumer apps, so concentration differs by segment. Astorg combined Hamilton Thorne and Cook Medical’s Reproductive Health business into an ART MedTech platform serving customers in more than 115 countries, while Progyny reported 555 clients and 6.689 million members at December 31, 2025.[9][10]
Pricing
Fertility technology is monetized through clinic and laboratory product sales, bundled treatment rates, employer benefits contracts, subscriptions and prescription services. Progyny states that clients pay bundled case rates that vary by fertility service and clinic location, while its population-based per-employee-per-month fees represented 1% of total revenue in 2025.[10]
Trends, drivers & challenges
Demand is supported by delayed parenthood, infertility, reproductive tourism, smartphone and wearable adoption, and advances in embryo selection, time-lapse imaging and AI-enabled diagnostics. Key constraints include high treatment costs, limited insurance coverage and social stigma; Grand View Research specifically identifies cost and coverage as market barriers.[3][8]
Consumer behavior & competition
In the United States, 13.7% of women ages 20–49 had ever used fertility services in 2022–2023; 6.9% had used infertility testing and 1.6% had used IVF or another ART procedure. Competition spans consumer apps, fertility clinics, employer-benefit platforms and ART equipment suppliers, with Flo reporting nearly 70 million monthly active users and close to 5 million paid subscribers in June 2024.[11][12]
M&A
Consolidation has focused on ART equipment, laboratory consumables, clinic networks and reproductive-health platforms. In December 2024, Astorg completed the take-private of Hamilton Thorne and acquired Cook Medical’s Reproductive Health business; in February 2025, NewGenIvf completed its acquisition of MicroSort technology, a transaction announced at $5 million.[9][13]
Regulation
U.S. ART clinics are required to report standardized cycle and outcome data under the Fertility Clinic Success Rate and Certification Act, with CDC surveillance estimated to cover about 98% of ART cycles. The CDC’s 2025 National Survey of Family Growth brief reports that 1.6% of women ages 20–49 used IVF or another ART procedure in 2022–2023.[11]
Latest news
The latest major U.S. industry milestone is the March 24, 2026 release of 2024 SART data: clinics reported 449,772 IVF treatment cycles, 97,549 cycles resulting in a live birth and 100,158 babies born through IVF. About 79% of embryo-transfer cycles used elective single-embryo transfer, reflecting continued emphasis on reducing multiple births.

02 Ranking

Top 8 Companies in the Fertility Tech Industry

The leading companies in the fertility tech industry, ranked on market impact, performance, momentum, innovation and brand popularity.

Updated November 18, 2026 · Next review December 18, 2026

Verdict

Natural Cycles stands out for FDA-cleared cycle tracking because it has more than 6 million users, while Nexpring Health focuses on ART lab workflow because it unites Cook Reproductive Health and Hamilton Thorne within an ART MedTech platform.

Ranked by Overall score · How we score ↓

Editor's top 3 picks

Where to start, by need.

  1. #1 Overall · Leader in fertility apps

    Natural Cycles

    SE

    Ranked #1 · 9.4 · Fertility apps

    Why we picked it: It combines FDA-cleared fertility-related contraceptive software with cycle tracking at scale through a consumer app.

  2. Leader in ART lab products

    Nexpring Health

    US

    Ranked #2 · 8.9 · ART lab products

    Why we picked it: Its portfolio covers ART lab workflow through devices, consumables, media, and lab processes across many ART operators.

  3. Leader in fertility devices & services

    CooperCompanies

    US

    Ranked #3 · 8.8 · Fertility devices & services

    Why we picked it: It sells IVF devices, consumables, and genomics and runs gamete services, with fertility sales reported at $524.6 million in fiscal 2025.

Pick 1 is the #1 company overall. Picks 2 and 3 are the highest-ranked companies in the top 5 that add a new segment.

Full ranking

Sort by
Top 8 companies in the fertility tech industry, 2026 – Gitnux ranking
#CompanyOverall ↓Company snapshot
1

Natural Cycles

Fertility apps · SE

9.4
2

Nexpring Health

ART lab products · US

8.9
3

CooperCompanies

Fertility devices & services · US

8.8
4

Ovation Fertility

IVF laboratories · US

8.7
5

Inito

At-home monitoring · US

8.6
6

Genea

Integrated IVF care and in-house fertility technology · AU

8.3
7

Oova

At-home reproductive hormone monitoring · US

7.8
8

Vitrolife

IVF media, incubators, genomics and lab software · SE

7.8

How we score

  • Impact (30%): scale and weight in the market (revenue, market share, employees, market position).
  • Performance (20%): recent revenue growth and operating margin; an analyst assessment where a company does not publish them.
  • Momentum (20%): growth trajectory and future potential.
  • Innovation (15%): R&D intensity and how technologically advanced the company is.

Popularity (brand search demand, 15%) counts toward Overall but is not published as a column. Overall leaves out what is not known.

Scale Scores are shown on a 7–10 scale with one decimal; bars start at 7.0.

Cadence Recalculated when new figures are published; next review December 18, 2026.

Independence. Rankings are editorially independent. Scores, ranks, picks and the verdict follow the method above; no company can pay to change them.

Cite this ranking

APA

Samuel Norberg. (2026, November 20). Top 8 companies in the fertility tech industry. In Fertility Tech Industry Statistics. Gitnux. https://gitnux.org/fertility-tech-industry-statistics/#top-companies

report visual · Projection

Number of assisted reproductive technology embryo transfers (United States)

Number of assisted reproductive technology embryo transfers grew from 157K in 2017 to 206K in 2022.

157.5K count
Start
+5.55%
CAGR · 5y
206.3K count
Projected
20172022
source-verifiedcdc.gov2022

04 Statistics

Technology & AI

AI and digital tooling have moved into routine embryology work, with 74.9% of respondents reporting use in 2024 and a 32.75% focus on embryo selection influence in 2025.

AI features and adoption in the fertility tech industry

  • 74.9% of respondents reported AI or digital-technology use in embryology laboratories, including time-lapse imaging, embryo or gamete selection, LIMS and electronic witnessing, in 2024.[1]
  • 53.22% of surveyed IVF specialists and embryologists reported regular or occasional AI use in reproductive medicine in 2025, up from 24.8% in 2022.[2]
  • 32.75% of 2025 survey respondents identified embryo selection as the aspect of reproductive-medicine work most influenced by AI.[2]

05 Statistics

Market Intelligence

Assisted reproductive technology software remains measurable across on-premises and cloud deployments, at $289.8 million in the U.S. and $902.8 million globally in 2023.

Market size and revenue in the fertility tech industry

  • USD 289.8 million was the United States assisted reproductive technology software market revenue in 2023, covering on-premises and cloud-based software.[3]
  • USD 902.8 million was the global assisted reproductive technology software market revenue in 2023, covering on-premises and cloud-based software.[3]
  • USD 188.27 million was the global fertility EHR software market size in 2025, covering electronic health-record software used by fertility clinics.[4]

Growth forecasts for the fertility tech industry

  • The global assisted reproductive technology software market is projected to reach USD 1,780.2 million by 2030, implying 10.2% CAGR from 2024 to 2030.[3]
  • The United States assisted reproductive technology software market is projected to reach USD 563.3 million by 2030, implying 10.0% CAGR from 2024 to 2030.[3]
  • The global fertility EHR software market is projected to reach USD 215.10 million by 2030, implying 2.70% CAGR from 2025 to 2030.[4]

06 Statistics

Finance

Funding shows both consumer and platform signals: $194.8 million was invested in fertility-related startups in 2024, including Flo’s $200 million Series C in July 2024.

Funding and investment in the fertility tech industry

  • $194.8 million was invested in fertility-related startups in 2024, according to Crunchbase data; the category includes fertility technology and related fertility startups globally.[5]
  • $200 million was raised in Flo Health’s Series C in July 2024 at a post-money valuation above $1 billion, providing a disclosed financing and valuation datapoint for a digital fertility-tracking platform.[6]
  • More than $14 billion was deployed into fertility investment between 2020 and 2025, including tech-enabled care platforms, employer-benefits infrastructure, consumer health and early-stage pharma; PwC defines the category broadly across fertility and reproductive-health opportunities.[7]

Key questions about the fertility tech industry

What is the fertility tech market anchored to in 2025?
The global in-vitro fertilization market was valued at $28.5 billion in 2025, which serves as a commercial proxy for the clinical and laboratory core of fertility tech.
How fast is the IVF market projected to grow from 2026 to 2033?
The IVF market is projected to reach $43.7 billion by 2033 from $30.1 billion in 2026, implying a 5.5% CAGR from 2026 to 2033.
Which companies lead the fertility tech industry?
Natural Cycles stands out for FDA-cleared cycle tracking because it has more than 6 million users, while Nexpring Health focuses on ART lab workflow because it unites Cook Reproductive Health and Hamilton Thorne within an ART MedTech platform.
What AI and digital shifts show up in embryology workflows?
In 2024, 74.9% of respondents reported AI or digital-technology use in embryology laboratories, and embryo selection was cited by 32.75% of 2025 respondents as the most influenced aspect.
How is the assisted reproduction software market structured and where is demand measured?
On-premises and cloud-based software make up the assisted reproductive technology software category, with $289.8 million in U.S. revenue and $902.8 million globally in 2023.
What regulatory reporting requirement affects IVF data in the U.S.?
U.S. ART clinics must report standardized cycle and outcome data under the Fertility Clinic Success Rate and Certification Act, with CDC surveillance estimated to cover about 98% of ART cycles.
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Samuel Norberg. (2026, November 20). Fertility Tech Industry Statistics. Gitnux. https://gitnux.org/fertility-tech-industry-statistics
MLA
Samuel Norberg. "Fertility Tech Industry Statistics." Gitnux, 20 Nov 2026, https://gitnux.org/fertility-tech-industry-statistics.
Chicago
Samuel Norberg. 2026. "Fertility Tech Industry Statistics." Gitnux. https://gitnux.org/fertility-tech-industry-statistics.